Development of potent and selective degraders of PI5P4Kγ
- 23 December 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 247, 115027
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 CA218278-02, R01 CA197329-03)
This publication has 37 references indexed in Scilit:
- Exploring phosphatidylinositol 5-phosphate 4-kinase functionAdvances in Biological Regulation, 2015
- Discovery and pharmacological characterization of a novel small molecule inhibitor of phosphatidylinositol-5-phosphate 4-kinase, type II, betaBiochemical and Biophysical Research Communications, 2014
- A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survivalOncogene, 2014
- Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null TumorsCell, 2013
- PtdIns5P and Pin1 in oxidative stress signalingAdvances in Biological Regulation, 2013
- A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate PreparationPLOS ONE, 2013
- Genomic tagging reveals a random association of endogenous PtdIns5P 4-kinases IIα and IIβ and a partial nuclear localization of the IIα isoformBiochemical Journal, 2010
- Phosphoinositide Signaling: New Tools and InsightsPhysiology, 2009
- Common variants at CD40 and other loci confer risk of rheumatoid arthritisNature Genetics, 2008
- Increased Insulin Sensitivity and Reduced Adiposity in Phosphatidylinositol 5-Phosphate 4-Kinase β−/− MiceMolecular and Cellular Biology, 2004